Shanghai Rightongene Biotechnology Co Ltd
688217
Company Profile
Business description
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Contact
No. 6055, Jinhai Road
Building 3
Fengxian District
Shanghai201499
CHNT: +86 2133282601
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
401
Stocks News & Analysis
stocks
Undervalued ASX share with pathway to positive cash flow
Higher sales and a new loan facility increase our conviction.
stocks
Taiwan Semiconductor earnings: Buoyant guidance backed by voracious AI demand
We’ve raised our fair value estimate of Taiwan Semiconductor stock.
stocks
Ahead of earnings, is Netflix a buy, a sell, or fairly valued?
Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,226.70 | 45.90 | 0.50% |
| CAC 40 | 8,313.12 | 17.84 | -0.21% |
| DAX 40 | 25,352.39 | 66.15 | 0.26% |
| Dow JONES (US) | 49,442.44 | 292.81 | 0.60% |
| FTSE 100 | 10,238.94 | 54.59 | 0.54% |
| HKSE | 26,809.74 | 113.88 | -0.42% |
| NASDAQ | 23,530.02 | 58.27 | 0.25% |
| Nikkei 225 | 54,039.91 | 70.59 | -0.13% |
| NZX 50 Index | 13,718.10 | 58.31 | 0.43% |
| S&P 500 | 6,944.47 | 17.87 | 0.26% |
| S&P/ASX 200 | 8,903.90 | 48.10 | 0.54% |
| SSE Composite Index | 4,103.30 | 9.30 | -0.23% |